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ABSTRACT
Elevated free fatty acids (FFAs) in obesity are known risk factors associated with chronic
inflammatory conditions including cardiovascular inflammation and thus cardiovascular disease
(CVD), the leading cause of death in the US. Anthocyanins from berries have the potential to
provide protection against inflammation in various tissues; however they are poorly absorbed
and undergo major transformations by the microbiome. The work presented in this dissertation
involves the development and utilization of an in vitro model to characterize the products of
colonic fermentation and absorption of blueberry and black raspberry pomace phenolics, and
evaluate the potential efficacy of these products compared to anthocyanin-rich extracts as antiinflammatory compounds in fatty acid-induced inflammation. A previous study identified
myristic and palmitic acids as the most inflammatory, and linoleic acid as least inflammatory. In
the first study, a model of colonic fermentation and transport through Caco-2 cells was used to
evaluate the changes in phenolic profile of blueberry and black raspberry pomaces. Phenolic
acids deriving from anthocyanin degradation were identified as the major products of berry
pomace digestion and absorption. The second study involved the use of palmitic acidstimulated HCAE and HCASM cells to evaluate the anti-inflammatory properties of anthocyaninrich extracts and phenolic acids produced by microbiota fermentation and transport across
Caco-2 monolayers using the prevention and intervention approaches. Protein and gene
expression of inflammation markers demonstrate that phenolic acids derived from
fermentation and absorption of both blueberry and black raspberry pomaces were equally or
more effective than anthocyanin-rich extracts in modulating the inflammatory response
through a proposed effect on NF-κB transcription, especially when used in the prevention
viii

approach. This suggests that phenolic acids may be responsible for some of the beneficial
effects of blueberries and black raspberries. We have also demonstrated that berry pomaces,
could be utilized in foods, providing anthocyanins and phenolic acids that may prevent
inflammation in cardiovascular cells.
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CHAPTER 1
LITERATURE REVIEW
1

1.1 INTRODUCTION
Blueberries and caneberries are some of the oldest fruits known to humans and have
been used not only for survival but medicinal purposes. Caneberries is a term encompassing
many common berries that grow on leafy canes at temperate climates around the world,
including raspberries, marionberries, blackberries, and boysenberries.2 These berries are widely
consumed in the US, with per capita consumptions of 0.09 lb blackberries, 1.5 lb blueberries,
and 0.75 lb raspberries according to the data from 2009.3 Blueberries and caneberries are rich
in phenolics, especially anthocyanins, which give them their characteristic red, blue, or purple
pigments and represent major sources of antioxidant capacity.4 Daily intakes of anthocyanins in
the United States had been estimated to range according to season from 180-215 mg/d,5
however the latest estimations indicate that anthocyanin consumption in the US is 12.5
mg/day/person.6 Studies of dietary anthocyanins have suggested various cardiovascular
benefits, including vascular anti-inflammatory effects and influence on blood vessels and
platelets.7-9 However, neither the mechanisms of action for the parent anthocyanins nor the
metabolites responsible for these anti-inflammatory effects are well understood.
As public awareness of dietary effects on health and wellness increases, consumers are
seeking foods to help preserve their health. Consumers are now considering “functional foods”
as alternatives or complements to Western medicine. Functional foods focus more on
prevention rather than intervention. For example, in the United States 6 out of 10 consumers
take some type of food supplement with the main objectives of feeling better, preventing
1

illness, and living longer.10 It has been estimated that consumption of functional foods that
contain effective bioactives in the US could result in annual health cost savings of $2 to $3
billion from anticipated prevention and reduction of the incidence of chronic disease.11
However, more detailed fundamental research is necessary to understand how bioactive
compounds in foods are digested, absorbed, metabolized and excreted in the body in order to
establish science-based claims that ethically and factually inform the consumers of the benefits
of the wide variety of potentially bioactive compounds found in foods.

1.2 REVIEW OF LITERATURE RELEVANT TO THIS APPLICATION
1.2.1 Cardiovascular Disease (CVD)
Cardiovascular disease (CVD) is a group of disorders of the heart and blood vessels
which include coronary heart disease, cerebrovascular disease, peripheral arterial disease,
rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary
embolism.12 CVD is the number one cause of death in the United States and the world,
accounting for close to 25% of all US deaths in 2009 (down 3.7% from the previous year) and
30% of the World deaths in 2008.13,14 Additionally, 8.1% of Americans have self-reported having
some type of CVD.15
According to the American Heart Association, atherosclerosis, a form of CVD, is a
process in which fat, cholesterol, cellular waste, calcium and other substances build up in the
inner lining of an artery; rupture of this plaque causes blood clots that can block blood flow to
the heart (heart attack), brain (stroke) or limbs (gangrene).16 It was previously believed that
atherosclerosis was primarily a “plumbing” problem, where plaque buildup would eventually
2

block the flow of blood thru the vascular system. However, research has revealed that
atherosclerosis derives from an inflammatory process, where proinflammatory stimuli trigger
the expression of adhesion molecules and chemoattractant factors (such as MCP-1) that allow
the infiltration of leukocytes to the intima and the maturation of monocytes into
macrophages.17,18 Macrophages then engulf modified lipoproteins and are converted into foam
cells, while other macrophages and T cells continue to amplify the inflammatory response by
the secretion of various cytokines and growth factors that also promote the migration and
proliferation of smooth muscle cells (SMCs) forming a fibrous cap over the foam cell cluster.
Eventually, inflammatory mediators weaken the fibrous cap and make it prone to rupture while
procoagulant tissue factor is produced. When the fibrous cap is ruptured, the tissue factor is
released forming a thrombus that can then create blockage in blood vessels as described
before.17
Research has shown that circulating free fatty acids (FFAs) induce inflammation, thus
making them a risk factor for CVD. An increase in plasma FFA concentrations induces
proinflammatory changes and oxidative stress including an increase in nuclear factor-κB (NF-κB)
binding activity and p65 expression without changes in inhibitor κB (IκB) in circulation mononuclear cells (MNCs). Reactive oxygen species (ROS) are generated by MNCs and
polymorphonuclear leukocytes (PMNs) in subjects with high levels of FFAs

19

. An increase in

macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, and an impairment
of the endothelium-dependent flow-mediated vasodilation was also observed as a result of
plasma FFA increase. Another study based on the Atherosclerosis Risk in Communities study,
showed that FFA levels were positively associated with an inflammation score quantifying levels
3

of six systemic inflammation markers (interleukin-6, C-reactive protein, orosomucoid, sialic
acid, white cell count, and fibrinogen) 20.
1.2.2 Bioactive Compounds in Blueberries and Caneberries
Several studies have identified different bioactive compounds in blueberries and
caneberries, mainly phenolics, however it is still not clear which compounds are the most
effective in protecting cardiovascular health or the mechanisms by which these compounds
produce an anti-inflammatory effect.
Anthocyanins represent 57-93% of the total phenolics found in blue and caneberries.4
Anthocyanins are a group of flavonoids commonly found in nature and present in many fruits
and vegetables as glycosides or acylglycosides of their respective aglycone anthocyanidins,
which are not usually found in fresh plant material.6,21 Six major anthocyanidins are widely
found in plants, namely cyanidin (Cy), delphinidin (Dp), malvidin (Mv), peonidin (Pn),
pelargonidin (Pg), and petunidin (Pt).6 All anthocyanins share the same basic anthocyanidin
skeleton (Figure 1.1), however they vary in the number and position of hydroxyl/methoxyl
groups on the skeleton, number and positions of the attached sugars, and the extent and
identity of sugar acylation.22

Anthocyanidin
Pelargonidin
Cyanidin
Delphinidin
Peonidin
Petunidin
Malvidin

R1

R2

R3

H
OH
OH
OMe
OMe
OMe

OH
OH
OH
OH
OH
OH

H
H
OH
H
OH
OMe

Figure 1.1. Basic structure of six major anthocyanins
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Major anthocyanins for blueberries and caneberries have been identified (Table 1.1),
namely cyanidin-3-glucoside in blackberries, malvidin 3-galactoside and malvidin 3-glucoside in
blueberries, cyanidin 3-sophoroside in red raspberries, and cyanidin 3-rutinoside in black
raspberries.21,23-25 Procyanidins, ellagitannins, flavonols, and ellagic acid derivatives have also
been identified as flavonols present in these fruits.23 Identified phenolics include flavonols
kaempferol, quercetin, and myricetin, and phenolic acids chlorogenic acid, p-coumaric acid,
caffeic acid, ferulic acid, p-hydoxybenzoic acid, gallic acid, and ellagic acid.24,26
Table 1.1. Average concentration of anthocyanins grouped by aglycones in US blueberries and
caneberries. Adapted from Wu et al., 2006.6
Total
Fruit
anthocyanins
Delphinidin Cyanidin Petunidin Pelargonidin Peonidin Malvidin Total per serving (mg)
Blackberry
244
0.7
245
353
Marionberry
297.7
1.7
1.1
300.5
433
Blueberry, cultivated
120.7
28.6
71.9
34.2
131.3 386.6
529
Blueberry, wild
141.1
66.3
87.6
36.9
154.6 486.5
705
Chokeberry
1478
2.3
1480
2147
Raspberry, black
669
16.7
1.1
687
845
Raspberry, red
90.2
1.9
92.1
116
mg anthocyanin/100 g fresh fruit

1.2.2.1 Anthocyanin Absorption and Excretion
In vitro studies have focused on the differential absorption of anthocyanins based on
their differences in aglycones, attached sugars, and chemical structure. Transport efficiency
using Caco-2 cell monolayers was 3-4%, with delphinidin 3-glucoside having the lowest
absorption/transport efficiency (0.72-1.18%)

and malvidin 3-glucoside the highest (2.01-

6.03%). Additionally, this study showed that anthocyanin bioavailability is reduced by more free
hydroxyl groups and less OCH3 groups, and increased by attached glucoses rather than
galactoses.27

5

Anthocyanin absorption and excretion studies carried out in humans agree that
absorption of ingested anthocyanins is very low (ppm), and may only raise human plasma
concentrations to the ng/ml order of magnitude. A study carried out in humans and rabbits fed
with black currant juice showed that both species absorbed a larger proportion of the
anthocyanin rutinosides than glucosides, and absorption in humans was proportional to dose.
Maximum anthocyanin plasma levels were observed at 30-45 minutes, for a maximum level of
50 ng/ml.28
In another study, individuals fed freeze-dried blueberry powder also absorbed most of
the individual anthocyanins, with serum concentrations of total anthocyanins ranging 5.43-16.9
ng/mL and peak concentrations at 4 h after consumption (average 13.1 ng/mL), however this
represented only 0.002-0.003% of the ingested amount. The most abundant anthocyanins
found in plasma after blueberry consumption were malvidin 3-galactoside, malvidin 3glucoside, and delphinidin 3-glucoside

(27, 20, and 10% of the total anthocyanins,

respectively).29
Studies carried out in Japan had also shown low absorption after intake of pure
anthocyanin preparations. In the first study average plasma concentration peaks were 11 μg/l
cyanidin 3-glucoside and trace amounts of cyanidin 3,5-diglucoside, but no free aglycones. In
the same study, anthocyanins were found in rat livers with peaks of 150 pmol/g at 15 min after
consumption of a dose of 320 mg/kg.30 In the second study, black currant anthocyanin peaks
ranged 5-73.4 nmol/l between 1.25-1.75 h after intake, with variations due to the individual
anthocyanin, however the anthocyanins were found in their intact forms.31

6

Human urinary excretion of anthocyanins up to 8 h after consumption of a pure
anthocyanin preparation have been reported as 0.05% of ingestion.31 Urinary excretion of
anthocyanins from juice has also been reported to represent only 0.035% during the first 4 h
after ingestion.28 Thus, by calculation we can determine that there are more than 90% of
consumed anthocyanins not accounted for that may reach colon.
1.2.2.2 Microbial Anthocyanin Metabolism in the Gut
Metabolism of phenolics, including anthocyanins, by gut microflora has been previously
investigated. A study carried out in France supplemented rats with red wine powder, and
identified microbial metabolites in the rats’ urine, including benzoic acids (hydroxybenzoic,
hippuric, vanillic), phenylacetic acids, phenylpropionic acids, p-coumaric acid, cinnamic acids
(caffeic, ferulic), and catechins. Most of these microbial metabolites were not initially present in
the supplemented powder.32
In vitro studies have also demonstrated microbial metabolism of anthocyanins. A Finnish
study treated pure anthocyanins (Cy-3-glu and cy-3-rut) with human fecal inoculum, and
identified cy-3-gluc and cyanidin aglycone as intermediary metabolites, followed by conversion
to protocatechuic acid as the major metabolite. Most anthocyanins disappeared after 1 h of
treatment with 5% fecal inoculum, indicating that microbial degradation involves
deglycosylation and breakdown of the anthocyanidin heterocycle.33 These results were
confirmed by later studies using porcine and human fecal inoculums, where anthocyanins were
also deglycosylated and hydrolized into metabolites incluiding protocatechuic acid (from
cyanidins), syringic acid (from malvidins), vanillic acid (from peonidins), 4-hydroxybenzoic acid
(from pelargonidis) and phloroglucinol aldehyde, for a total disappearance of anthocyanins
7

after 0.5-2 h of treatment.34,35 Phenolic acids derived from the B ring of the correspondent
anthocyanidin, while aldehydes derive from the A ring.35
All authors suggested that these metabolites, rather than their intact precursors, may be
responsible for the beneficial effects of anthocyanins, since these metabolites are more readily
absorbed and resistant to further metabolism.32-35 However, models utilizing anaerobic
fermentation for the production of these metabolites from berry pomaces have not been
explored.
1.2.2.3 Anthocyanin Toxicology
Limited studies have been performed on the toxicity of anthocyanins. An initial in vitro
study tested a cyanidin 3-glycoside rich extract from black carrot on HT29 human colon cells,
and observed toxicity after 24 h in the form of reduced cell viability (88-175 μM) and cell
growth (45 μM), and induction of DNA damage (88-175 μM).36 In another study, an
anthocyanin-rich extract from strawberries (mainly pelargonidins) showed to low toxicity in
human prostate cells. Only a 10% decrease in cell survival was observed at 25 μg extract/ml
media for both tumorigenic and normal prostate cells. In contrast, 4-6 μg/ml of the total
strawberry extract, containing other phenolics, displayed a 50% reduction in survival for both
prostate and breast cells.37
Hormesis, a non-linear toxicity effect, has been proposed as an alternative regulation
mechanism by which plant phenolics such as chalcone, ferulic acid, epicatechin, and luteolin
exert their health benefits.38 Hormesis is defined as a “dose-response relationship phenomenon
characterized by low-dose stimulation and high-dose inhibition” (Figure 1.2), in other words it is
a U-shaped dose-response curve in which low doses of a compound cause a beneficial effect,
8

while high doses induce toxicity.1,39,40 This is not a new
concept,

as

Paracelsus

(1492-1591),

had

first

described that the toxicity of any substance was
dependent on dose, and noted that various toxic
substances could be beneficial in small quantities with
his famous quote "All substances are poisons; there is
none which is not a poison. The right dose
differentiates a poison from a remedy".41 Further

Figure 1.2. The classical hormetic Ushaped dose response illustrating a
reduction of dysfunction at low
doses.1

research is required to determine the hormetic effects of anthocyanins.
1.2.3 Anthocyanins and Heart Health
Numerous health benefits of anthocyanins have been reported including improved brain
function, modulation of obesity, antioxidant effects, improvement of cardiovascular function,
cancer prevention, and anti-inflammatory effects.22 We will focus this review on antiinflammatory effects and the improvement of cardiovascular function.
The anti-inflammatory effects of anthocyanins have mainly been studied in vitro. The
aglycones delphinidin and cyanidin, but not malvidin, peonidin, or petunidin, have shown to
inhibit LPS-induced COX-2 expression in murine macrophages, possibly due to the odihydroxyphenyl on the B ring of the anthocyanidin structure.42 Delphinidin dose-dependently
inhibited

COX-2

expression,

IκB-α

degradation,

p65

nuclear

translocation,

c-Jun

phosphorylation, and the activators of MAPK (JNK, ERK, and p38 kinase); thus inhibition of COX2 expression by delphinidin occurred through the blockage of pathways mediated by MAPK,
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including the activation of nuclear factor-κB (NF-κB), activator protein-1 (AP-1) and
CCAAT/enhancer-binding protein (C/EBPd).42
Cyanidin, but not its correspondent anthocyanins (cyanidin 3-glucosylrutinoside,
cyanidin 3-rhamnoside, cyanidin 3-glucoside) from tart cherries, have demonstrated antiinflammatory effects by inhibiting the enzymes prostaglandin endoperoxide H synthase-1 and 2 (PGHS-1, and -2), which are responsible for the conversion of arachidonic acid to
prostaglandins. Cyanidin IC50 against PGHS-1 and PGHS-2 was 90 and 60 mM respectively
(compare to naproxen and ibuprofen, with IC50 11 and 25 mM).43 Similarly, cyanidin (5 μM) and
anthocyanins isolated from tart and sweet cherries, cranberry, bilberry, elderberry, strawberry,
blackberry, and raspberry have shown to significantly inhibit COX-1 and COX-2 enzyme activity
at 125 μg/ml.44 Cyanidin 3-glucoside has also been observed to dose-dependently reduce LPSinduced NO and PGE2 in mice eye aqueous humor, with effects observed after anthocyanin
intravenous injection of 10mg. These results suggest a decrease in NO-induced COX-2
expression, putatively through suppression of NF-kB activity. Additionally, this effect was
stronger when a Russian berry extract, containing cy 3-glu, was administered, indicating
synergistic effects between anthocyanins and other phenolics in the anti-inflammatory
properties of berries.45 Similar effects were observed in LPS-stimulated THP-1 monocytes
pretreated with cy 3-glu. Pretreatment with as low as 1 μM cy 3-glu significantly and dosedependently reduced gene and protein expression of iNOS and COX-2, as well as release of NO
and PGE2, by up-regulation of liver X receptor α (LXRα) transcriptional activation. Furthermore,
the latter led to suppression of NF-kB activity, and an effect on functional transcription but not
nuclear translocation was suggested.46
10

Polyphenol-rich extracts from blueberries at 50 μg/ml have effectively reduced LPSinduced inflammatory mediators inducible nitric oxide synthase (iNOS) and COX-2 in microglial
cells (macrophages in brain and spinal cord). The modulation mechanism was through the
suppression of the iNOS and COX-2 promoter activity and NF-kB nuclear translocation.47
Treatment of polymorphonuclear cells (PMN) with 0.01-1 g/l of an anthocyanin-rich juice blend
containing mainly cyanidin-based anthocyanins from acai reduced migration towards
inflammatory stimuli bacterial peptide f-Met-Leu-Phe (fmlp), leukotriene B4 (LTB4), and IL-8.48
Treatment of LPS/IFN-γ-activated RAW 264.7 macrophages with cyanidin or blueberry
concentrate also reduced NO (31 μM, 125 μg/ml) but increased TNF-α (125 μM, 250 μg/ml)
production, a mechanism that has been proposed to be responsible for chemopreventive and
anti-inflammatory potential.49
Anthocyanin and hydroxycinnamic acid from blueberries and cranberries have been
shown to effectively reduce TNFα-induced inflammatory mediators IL-8, MCP-1, and
intercellular adhesion molecule 1 (ICAM-1). Pretreatment of human microvascular endothelial
cells with these compounds at 0.1 mg/ml significantly reduced IL-8 and ICAM-1, while only
anthocyanins reduced MCP-1.7
Cyanidin 3-glucoside in the form of blackberry juice or pure anthocyanin has effectively
reduced peroxynitrite-induced vascular hyporeactivity in thoracic aortic rings and impairment
of the endothelium-dependent relaxations at concentrations as low as 14.5 ppm from juice or
0.0085 μM pure anthocyanins in vitro.50 In contrast, a similar study demonstrated that fractions
from red raspberries rich in phenolic acids lambertianin C and sanguiin H-6, but not
anthocyanins, promoted vasorelaxation of rabbit thoracic aorta.51
11

In vivo, blueberry supplementation in the diet has resulted in significant
cardioprotective and anti-inflammatory effects. Rats fed a 2% blueberry diet for 3 months
showed reduced cardiomyocyte mitochondrial permeability transition (MPT) susceptibility to
reactive oxygen species (ROS), which was proposed as the cellular mechanism of
cardioprotection.52 Additionally, blueberry fed rats had smaller myocardial infarction (MI) areas
and 40% less inflammatory cells (monocytes and lymphocytes) in cardiac tissue following
induced ischemia by arterial ligation. Furthermore, blueberry diet, even when started after MI,
attenuated cardiac remodeling and MI expansion.52 Tart cherry anthocyanins have also shown
to effectively reduce carrageenan or complete Freund’s adjuvant induced paw inflammation in
mice gavaged with 85-400 mg anthocyanins/kg bw. The anti-inflammatory effect, measured by
paw withdrawal and paw thickness, was comparable to indomethacin at 5 mg/kg, and the
mechanism of action was suggested to be the inhibition of COX-1 and -2 mediated synthesis of
prostaglandins.53 In another study, mice fed with 10% or 50% tart cherry juice dilutions for 14
days showed significant improvements in lipid oxidation in liver and superoxide dismutase in
liver and blood. Furthermore, COX-2 activity of peritoneal macrophages obtained from these
mice was dose-dependently inhibited in 33-41%.54 In contrast, a previous study did not report
significant differences in various markers of coronary health when healthy adults were
supplemented with 750 ml/day of cranberry juice. Markers included homocysteine, HDL, LDL,
and total cholesterol, triglycerides, plasma antioxidant potential, glutathione peroxidase,
catalase, and superoxide dismutase activities.55 These results, however, may be considered
positive, as the subjects preserved their health.

12

1.3 REFERENCES
1.
Calabrese, E. J.; Baldwin, L. A. Hormesis: U-shaped dose responses and their centrality in
toxicology. Trends Pharmacol. Sci. 2001, 22, 285-291.
2.
Ravai, M. Caneberries: An important food in a healthy diet. Nutrition Today 1996, 31,
143-147.
3.
Service, E. R. Food availability (per capita) data system.
http://www.ers.usda.gov/Data/FoodConsumption/ (accessed November 9, 2011).
4.
Moyer, R. A.; Hummer, K. E.; Finn, C. E.; Frei, B.; Wrolstad, R. E. Anthocyanins, phenolics,
and antioxidant capacity in diverse small fruits: vaccinium, rubus, and ribes. J. Agric. Food
Chem. 2002, 50, 519-25.
5.
Kuhnau, J. The flavonoids. A class of semi-essential food components: their role in
human nutrition. World Rev. Nutr. Diet. 1976, 24, 117-91.
6.
Wu, X.; Beecher, G. R.; Holden, J. M.; Haytowitz, D. B.; Gebhardt, S. E.; Prior, R. L.
Concentrations of anthocyanins in common foods in the United States and estimation of
normal consumption. J. Agric. Food Chem. 2006, 54, 4069-75.
7.
Youdim, K. A.; McDonald, J.; Kalt, W.; Joseph, J. A. Potential role of dietary flavonoids in
reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. The
Journal of nutritional biochemistry 2002, 13, 282-288.
8.
Andriambeloson, E.; Magnier, C.; Haan-Archipoff, G.; Lobstein, A.; Anton, R.; Beretz, A.;
Stoclet, J. C.; Andriantsitohaina, R. Natural dietary polyphenolic compounds cause endotheliumdependent vasorelaxation in rat thoracic aorta. J. Nutr. 1998, 128, 2324-33.
9.
Rechner, A. R.; Kroner, C. Anthocyanins and colonic metabolites of dietary polyphenols
inhibit platelet function. Thromb. Res. 2005, 116, 327-34.
10.
Brower, V. A nutraceutical a day may keep the doctor away. Consumers are turning
increasingly to food supplements to improve well-being when pharmaceuticals fail. EMBO Rep.
2005, 6, 708-11.

13

11.
Jew, S.; AbuMweis, S. S.; Jones, P. J. H. Evolution of the human diet: Linking our
ancestral diet to modern functional foods as a means of chronic disease prevention. J. Med.
Food 2009, 12, 925-934.
12.

WHO, Cardiovascular Diseases (CVD). In Fact Sheets, 2011.

13.
Kochanek, K. D.; Xu, J.; Murphy, S. L.; Miniño, A. M.; Kung, H.-C. Deaths: Preliminary
Data for 2009. National Vital Statistics Reports 2011, 59.
14.

WHO, Causes of death 2008. In Geneva, World Health Organization: 2011.

15.
Roger, V. L.; Go, A. S.; Lloyd-Jones, D. M.; Adams, R. J.; Berry, J. D.; Brown, T. M.;
Carnethon, M. R.; Dai, S.; de Simone, G.; Ford, E. S.; Fox, C. S.; Fullerton, H. J.; Gillespie, C.;
Greenlund, K. J.; Hailpern, S. M.; Heit, J. A.; Ho, P. M.; Howard, V. J.; Kissela, B. M.; Kittner, S. J.;
Lackland, D. T.; Lichtman, J. H.; Lisabeth, L. D.; Makuc, D. M.; Marcus, G. M.; Marelli, A.;
Matchar, D. B.; McDermott, M. M.; Meigs, J. B.; Moy, C. S.; Mozaffarian, D.; Mussolino, M. E.;
Nichol, G.; Paynter, N. P.; Rosamond, W. D.; Sorlie, P. D.; Stafford, R. S.; Turan, T. N.; Turner, M.
B.; Wong, N. D.; Wylie-Rosett, J. Heart disease and stroke statistics--2011 update: a report from
the American Heart Association. Circulation 2011, 123, e18-e209.
16.
American Heart Association, Heart and stroke encyclopedia In American Heart
Association: 2011.
17.
Packard, R. R.; Libby, P. Inflammation in atherosclerosis: from vascular biology to
biomarker discovery and risk prediction. Clin. Chem. 2008, 54, 24-38.
18.
Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J.
Med. 2005, 352, 1685-95.
19.
Tripathy, D.; Mohanty, P.; Dhindsa, S.; Syed, T.; Ghanim, H.; Aljada, A.; Dandona, P.
Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy
subjects. Diabetes 2003, 52, 2882-7.
20.
Pankow, J. S.; Duncan, B. B.; Schmidt, M. I.; Ballantyne, C. M.; Couper, D. J.; Hoogeveen,
R. C.; Golden, S. H. Fasting plasma free fatty acids and risk of type 2 diabetes: the
atherosclerosis risk in communities study. Diabetes Care 2004, 27, 77-82.

14

21.
Tulio, A. Z., Jr.; Reese, R. N.; Wyzgoski, F. J.; Rinaldi, P. L.; Fu, R.; Scheerens, J. C.; Miller,
A. R. Cyanidin 3-rutinoside and cyanidin 3-xylosylrutinoside as primary phenolic antioxidants in
black raspberry. J. Agric. Food Chem. 2008, 56, 1880-8.
22.
Prior, R. L.; Wu, X. Anthocyanins: Structural characteristics that result in unique
metabolic patterns and biological activities*. Free Radical Res. 2006, 40, 1014-1028.
23.
Siriwoharn, T.; Wrolstad, R. E.; Finn, C. E.; Pereira, C. B. Influence of Cultivar, Maturity,
and Sampling on Blackberry (Rubus L. Hybrids) Anthocyanins, Polyphenolics, and Antioxidant
Properties. J. Agric. Food Chem. 2004, 52, 8021-8030.
24.
Gao, L.; Mazza, G. Quantitation and Distribution of Simple and Acylated Anthocyanins
and Other Phenolics in Blueberries. J. Food Sci. 1994, 59, 1057-1059.
25.
Mullen, W.; Stewart, A. J.; Lean, M. E. J.; Gardner, P.; Duthie, G. G.; Crozier, A. Effect of
Freezing and Storage on the Phenolics, Ellagitannins, Flavonoids, and Antioxidant Capacity of
Red Raspberries. J. Agric. Food Chem. 2002, 50, 5197-5201.
26.
Häkkinen, S.; Heinonen, M.; Kärenlampi, S.; Mykkänen, H.; Ruuskanen, J.; Törrönen, R.
Screening of selected flavonoids and phenolic acids in 19 berries. Food Res. Int. 1999, 32, 345353.
27.
Yi, W.; Akoh, C. C.; Fischer, J.; Krewer, G. Absorption of anthocyanins from blueberry
extracts by caco-2 human intestinal cell monolayers. J. Agric. Food Chem. 2006, 54, 5651-8.
28.
Nielsen, I. L.; Dragsted, L. O.; Ravn-Haren, G.; Freese, R.; Rasmussen, S. E. Absorption
and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic
rabbits. J. Agric. Food Chem. 2003, 51, 2813-20.
29.
Mazza, G.; Kay, C. D.; Cottrell, T.; Holub, B. J. Absorption of anthocyanins from
blueberries and serum antioxidant status in human subjects. J. Agric. Food Chem. 2002, 50,
7731-7.
30.
Miyazawa, T.; Nakagawa, K.; Kudo, M.; Muraishi, K.; Someya, K. Direct Intestinal
Absorption of Red Fruit Anthocyanins, Cyanidin-3-glucoside and Cyanidin-3,5-diglucoside, into
Rats and Humans. J. Agric. Food Chem. 1999, 47, 1083-1091.

15

31.
Matsumoto, H.; Inaba, H.; Kishi, M.; Tominaga, S.; Hirayama, M.; Tsuda, T. Orally
Administered Delphinidin 3-Rutinoside and Cyanidin 3-Rutinoside Are Directly Absorbed in Rats
and Humans and Appear in the Blood as the Intact Forms. J. Agric. Food Chem. 2001, 49, 15461551.
32.
Gonthier, M. P.; Cheynier, V.; Donovan, J. L.; Manach, C.; Morand, C.; Mila, I.; Lapierre,
C.; Remesy, C.; Scalbert, A. Microbial aromatic acid metabolites formed in the gut account for a
major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr.
2003, 133, 461-7.
33.
Aura, A. M.; Martin-Lopez, P.; O'Leary, K. A.; Williamson, G.; Oksman-Caldentey, K. M.;
Poutanen, K.; Santos-Buelga, C. In vitro metabolism of anthocyanins by human gut microflora.
Eur. J. Nutr. 2005, 44, 133-42.
34.
Keppler, K.; Humpf, H.-U. Metabolism of anthocyanins and their phenolic degradation
products by the intestinal microflora. Bioorg. Med. Chem. 2005, 13, 5195-5205.
35.
Fleschhut, J.; Kratzer, F.; Rechkemmer, G.; Kulling, S. Stability and biotransformation of
various dietary anthocyanins in vitro. Eur. J. Nutr. 2006, 45, 7-18.
36.
Glei, M.; Matuschek, M.; Steiner, C.; Bohm, V.; Persin, C.; Pool-Zobel, B. L. Initial in vitro
toxicity testing of functional foods rich in catechins and anthocyanins in human cells. Toxicol. In
Vitro 2003, 17, 723-9.
37.
Weaver, J.; Briscoe, T.; Hou, M.; Goodman, C.; Kata, S.; Ross, H.; McDougall, G.; Stewart,
D.; Riches, A. Strawberry polyphenols are equally cytotoxic to tumorigenic and normal breast
cells and prostate cell lines. Int. J. Oncol. 2008, 34, 777-786.
38.
Son, T. G.; Camandola, S.; Mattson, M. P. Hormetic dietary phytochemicals. NeuroMol.
Med. 2008, 10, 236-46.
39.
Calabrese, E. J.; Baldwin, L. A. Hormesis: the dose-response revolution. Annu. Rev.
Pharmacol. Toxicol. 2003, 43, 175-97.
40.
Calabrese, E. J.; Baldwin, L. A. The Hormetic Dose-Response Model Is More Common
than the Threshold Model in Toxicology. Toxicological Sciences 2003, 71, 246-250.

16

41.

Paracelsus, Avr. Philip. sumptibus I. Antonij, & Samuelis De Tournes: Genevæ,, 1658.

42.
Hou, D. X.; Yanagita, T.; Uto, T.; Masuzaki, S.; Fujii, M. Anthocyanidins inhibit
cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and
molecular mechanisms involved. Biochem. Pharmacol. 2005, 70, 417-25.
43.
Wang, H.; Nair, M. G.; Strasburg, G. M.; Chang, Y. C.; Booren, A. M.; Gray, J. I.; DeWitt, D.
L. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from
tart cherries. J. Nat. Prod. 1999, 62, 294-6.
44.
Seeram, N. P.; Momin, R. A.; Nair, M. G.; Bourquin, L. D. Cyclooxygenase inhibitory and
antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001, 8, 362-9.
45.
Ohgami, K.; Ilieva, I.; Shiratori, K.; Koyama, Y.; Jin, X. H.; Yoshida, K.; Kase, S.; Kitaichi, N.;
Suzuki, Y.; Tanaka, T.; Ohno, S. Anti-inflammatory effects of aronia extract on rat endotoxininduced uveitis. Invest. Ophthalmol. Visual Sci. 2005, 46, 275-81.
46.
Wang, Q.; Xia, M.; Liu, C.; Guo, H.; Ye, Q.; Hu, Y.; Zhang, Y.; Hou, M.; Zhu, H.; Ma, J.; Ling,
W. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor
alpha activation in THP-1 macrophages. Life Sci. 2008, 83, 176-84.
47.
Lau, F. C.; Joseph, J. A.; McDonald, J. E.; Kalt, W. Attenuation of iNOS and COX2 by
blueberry polyphenols is mediated through the suppression of NF-κB activation. J. Funct. Foods
2009, 1, 274-283.
48.
Jensen, G. S.; Wu, X.; Patterson, K. M.; Barnes, J.; Carter, S. G.; Scherwitz, L.; Beaman, R.;
Endres, J. R.; Schauss, A. G. In vitro and in vivo antioxidant and anti-inflammatory capacities of
an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, doubleblinded, placebo-controlled, crossover study. J. Agric. Food Chem. 2008, 56, 8326-33.
49.
Wang, J.; Mazza, G. Inhibitory effects of anthocyanins and other phenolic compounds on
nitric oxide production in LPS/IFN-gamma-activated RAW 264.7 macrophages. J. Agric. Food
Chem. 2002, 50, 850-7.
50.
Serraino, I.; Dugo, L.; Dugo, P.; Mondello, L.; Mazzon, E.; Dugo, G.; Caputi, A. P.;
Cuzzocrea, S. Protective effects of cyanidin-3-O-glucoside from blackberry extract against
peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci. 2003, 73, 1097-114.

17

51.
Mullen, W.; McGinn, J.; Lean, M. E.; MacLean, M. R.; Gardner, P.; Duthie, G. G.; Yokota,
T.; Crozier, A. Ellagitannins, flavonoids, and other phenolics in red raspberries and their
contribution to antioxidant capacity and vasorelaxation properties. J. Agric. Food Chem. 2002,
50, 5191-6.
52.
Ahmet, I.; Spangler, E.; Shukitt-Hale, B.; Juhaszova, M.; Sollott, S. J.; Joseph, J. A.;
Ingram, D. K.; Talan, M. Blueberry-enriched diet protects rat heart from ischemic damage. PLoS
One 2009, 4, e5954.
53.
Tall, J. M.; Seeram, N. P.; Zhao, C.; Nair, M. G.; Meyer, R. A.; Raja, S. N. Tart cherry
anthocyanins suppress inflammation-induced pain behavior in rat. Behav. Brain Res. 2004, 153,
181-8.
54.
Saric, A.; Sobocanec, S.; Balog, T.; Kusic, B.; Sverko, V.; Dragovic-Uzelac, V.; Levaj, B.;
Cosic, Z.; Macak Safranko, Z.; Marotti, T. Improved antioxidant and anti-inflammatory potential
in mice consuming sour cherry juice (Prunus Cerasus cv. Maraska). Plant Foods Hum. Nutr. (N.
Y., NY, U. S.) 2009, 64, 231-7.
55.
Duthie, S. J.; Jenkinson, A. M.; Crozier, A.; Mullen, W.; Pirie, L.; Kyle, J.; Yap, L. S.;
Christen, P.; Duthie, G. G. The effects of cranberry juice consumption on antioxidant status and
biomarkers relating to heart disease and cancer in healthy human volunteers. Eur. J. Nutr. 2006,
45, 113-22.

18

CHAPTER 2
IN VITRO MODEL FOR ASSESSING THE COLONIC FERMENTATION AND ABSORPTION OF
BLUEBERRY AND BLACK RASPBERRY POMACE PHENOLICS

2.1 INTRODUCTION
Obesity is a major health problem in the United States, where according to the latest
information from the Center for Disease Control and Prevention (CDC), 35.7% of adults and
16.9% of children and adolescents are obese.1 It is now widely accepted that chronic
inflammation is a major consequence of obesity, and that this type of inflammation may be the
underlying cause of many other chronic conditions, to the extent that it has been called “the
secret killer”.2 Obesity-induced inflammation has been closely linked with chronic conditions
including insulin resistance, type 2 diabetes, and cardiovascular disease.3,4 The goal of
prevention or delay of these conditions has led the scientific community to explore dietary
interventions including bioactives derived from fruits.
Fruit juice production, including berry juices, is a growing industry around the world. For
example, 17% of the 2008 US blueberry production (around 225 million lb) was allocated in the
non-alcoholic beverage industry, while 95% of the Oregon Valley black raspberry production
(which accounts for most of the black raspberries produced in the US) is destined to processed
products including individually quick frozen (IQF) berries, purees, and juice concentrates.5,6
Berry juice yields range 50-85%, resulting in at least 15% byproducts, mainly pomace consisting
of seeds, hulls, and pulp.7 These byproducts used to be considered of low value, and were
mainly destined for composting or animal feed. However, studies have shown that berry and
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grape pomaces are rich in anthocyanins, polyphenols, and dietary fiber, and are potential
ingredients for functional foods.8-10
Anthocyanins and phenolics derived from berries are recognized as potent
antioxidants.11-13 While antioxidant activity is readily measured chemically the in vivo effects of
antioxidants remain in doubt. Emerging literature suggests that the anti-inflammatory effects of
these compounds may be of greater significance in vivo.14-16 Studies have identified antiinflammatory effects of polyphenols including anthocyanins in several tissues including lungs,
joints, and macrophages by inhibiting the production of nitric oxide and TNF-α.17-20 Fruits, like
berry fruits and fruit pomace contain substantial levels of fiber.21,22 Fermentable fiber derived
from plant tissues can produce short-chain fatty acids (SCFAs) as a result of fermentation by the
microbiome. It has been demonstrated that the butyrate produced during the fermentation of
dietary fiber is the preferred substrate for colon cells.23 Furthermore, SCFAs derived from fiber
fermentation have been linked to the control of healthy body weight by stimulating the
expression of gut hormones peptide YY (PYY) and glucagon-like peptide (GLP)-1 in in vivo
studies.24 However, the anti-inflammatory and SCFA-producing effects of berries, and especially
their byproducts, have not been explored in depth.
This study evaluated of blueberry and black raspberry pomaces as sources of bioactive
compounds including anthocyanins and other phenolics, and fermentable fiber. Models for the
fermentation of berry pomaces and absorption of phenolics deriving from the aforementioned
fermentation have been established. These models offer low cost and time efficient
alternatives to larger-scale in vivo testing. Demonstrating the anti-inflammatory and overall
health-promoting effect of these byproducts will offer insight for their further use as food
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ingredients, thus minimizing waste in juice production and offering a new economic
opportunity for juice producers.

2.2 MATERIALS AND METHODS
2.2.1 Materials
Blueberry (Vaccinium spp.) and black raspberry (Rubus occidentalis ‘Munger’) pomaces
were provided by Milne Fruit Products (Prosser, WA) and were freeze dried in a VirTis Genesis
pilot lyophylizer (Warminster, PA). Digestive enzymes, phenolic acids (gallic, protocatechuic,
cinnamic, chlorogenic, caffeic, p-coumaric, and ferulic), and phloroglucinol aldehyde were
purchased from Sigma Aldrich (St. Louis, MO). Human epithelial colorectal adenocarcinoma
(Caco-2) cells were purchased from ATCC (Manassas, VA). Cell culture media, buffers, and
materials were obtained from Life Technologies (Carlsbad, CA). All other reagents were of
analytical or HPLC grade accordingly and obtained from Fisher Scientific (Waltham, MA). Water
was Milli Q (Millipore Corporation, MA) for all the studies.
2.2.2 Digestion and Fermentation of Berry Pomaces
Digestion of berry pomaces was based on the method previously employed by Fazzari
and others for cherries.25 In this method, pepsin-HCl simulates gastric digestion, while
pancreatin and bile salts simulate the small intestine conditions. Briefly, 100 g of homogenized
pomace acidified to pH 2 with HCl (60 g dry pomace + 100 ml water) were mixed with 31500
units of pepsin and incubated at 37 °C while shaking at 100 rpm for 2 h. After incubation, the
pH was adjusted to 7.5 with NaOH or NAHCO3, and 20 g of the digest were mixed with 5 ml
enzyme solution (pancreatin 4 mg/ml and porcine bile extract 25mg/ml) in a 90 ml
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polypropylene screw cap container and incubated as before. The digest was microwaved 3-5
minutes to denature enzymes, filtered through Fisher P8 filter paper, washed with ethanol to
remove hydrolyzed sugars and aminoacids, filtered, and dried overnight. The final dry digest
was frozen at -20 °C until fermentation could be conducted.
A modified in vitro anaerobic fermentation system established by our research group
was used to mimic colonic fermentation of berry pomace. Briefly, the system consists in two
vessels, the fermentation mixture preparation vessel, and the anaerobic incubation system.
Each preparation vessel contains 350 ml of anaerobic solution, consisting in a 9:1 ratio of
autoclaved solution A (NaHCO3 0.14 M, hemin 8.7 μM, menadione 0.39 μM, resazurin 4.4 μM
as redox indicator) and solution B (NaCl 0.48 M, K2HPO4 0.02 mM, cysteine-HCl 0.63 mM),
adjusted to pH 7.5 with NaOH.26 Fecal inoculum was prepared from freshly collected human
feces from healthy donors kept at 0°C within 4 hours of collection then transferred to -80°C.
Fifty grams of feces were homogenized with 200 ml of anaerobic solution, filtered through
cheese cloth or a filter whirlpak bag, transferred into a sterile bag, and incubated at 37 °C for 1
hour under anaerobic conditions using a BD GasPak™ EZ Pouch System. Following incubation,
50 ml of the anaerobic inoculum was added to each fermenter vessel containing 10 g of
digested pomace and the vessels were flushed with 80% N2, 10% H2, and 10% CO2 for 10 min
while incubating at 37 °C. An anaerobic strip was added to each vessel to verify the anaerobic
conditions. To simulate colonic fermentation conditions, the contents from the incubated
vessels were aseptically transferred to 50 ml centrifuge tubes, sealed leaving little or no head
space, and placed in a hermetically sealed container using an anaerobic environment
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generating pouch system. The container was incubated at 37 °C while shaking for up to 24 h, at
which time the vessels were removed for analysis.
The contents of the fermentation vessels were centrifuged, and the supernatants were
analyzed by HPLC for anthocyanin and phenolic acid content. Supernatants were also sterilefiltered for transport studies.
2.2.3 Anthocyanin Extraction and Characterization
Anthocyanin rich fractions for cell culture studies were extracted from pomace using the
acidified-methanol method.27 Briefly, 50 g of ground material were homogenized with 100 ml
of acidified methanol (0.01% v/v HCl in methanol) and macerated for 1 h. The slurry was filtered
by vacuum suction through Whatman 1 filter paper and re-extracted two times until a faintcolored extract was obtained. Methanol was evaporated from the filtrate using a rotary
evaporator, freeze-dried, and re-dissolved to a final known volume with sterile water, and
sterile filtered. Anthocyanin quantification in this extract was performed by HPLC analysis.28
Phenolic and anthocyanin profiles were determined by HPLC using the method
previously developed in our laboratory by Jang and Xu.29 Briefly, the HPLC system consisted in a
Discovery C18 column (3 mm i.d. x 25 cm) by Supelco (Bellefonte, PA), Waters 2690 separation
module, 996 photodiode array detector, and Millenium32 chromatography manager. The
mobile phase consisted in a mixture of 0.4% TFA in water (A) and acetonitrile (B), with the
percentage of A=0.4% TFA in water ramped from 100-90% in 5 minutes, and then from 90-45%
at 45 min with 0.8 ml/min constant flow rate. Anthocyanin extracts from pomace were used for
quantification, and chromatograms were obtained at 264 nm (gallic, protocatechuic, and
cinnamic acid), 232 nm (phloroglucinol aldehyde), 314 nm (chlorogenic, caffeic, p-coumaric, and
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ferulic acid), and 520 nm (anthocyanins). Quantification was achieved through comparison with
previously performed phenolic or anthocyanin standard curves.
2.2.4 Cell Culture
Cell lines of heterogeneous human epithelial colorectal adenocarcinoma (Caco-2) were
grown using supplemented Cascade Medium DMEM (Gibco, Portland, OR). Cells were fed every
other day until 80% confluence and split at 1 to 3 or 1 to 2. Cascade trypsin solution was applied
to lift the cells; and it was subsequently neutralized with CMF-PBS + 10% FBS. Cells were spun
down and resuspended in media. For all the treatments, cells were incubated at 37 °C with 5%
CO2 in a humidified incubator (Sanyo Biomedical, Wood Dale, IL).
2.2.5 Transport Study
Apical to basolateral transport of anthocyanin rich fractions and pomace digests was
assessed using a Caco-2 monolayer model previously established for drug transport studies.30-32
Briefly, Caco-2 cells were seeded on non-coated Costar Transwell permeable supports with 0.4
mm polycarbonate membrane from Corning (Lowell, MA) at 2.6 x 105 cells per cm2. The plating
media (DMEM supplemented with 10% FBS, 1% L-glutamate, 1% NEAA and 5% antibioticantimycotic solution) was replaced 6-16 h after plating and then every 48 h up to 21-29 days to
allow differentiation. Transepithelial electrical resistance (TEER) of the monolayers was
measured routinely before and after the transport experiment using a Millicell®-ERS system
(Millipore, Bedford, MA).
The transport experiment was conducted between days 21-29. The compounds of
interest (anthocyanin rich extracts or digests) were diluted to 0.1mM in transport medium
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consisting in Hank’s balanced salts solution (HBSS) supplemented with 25mM glucose adjusted
to pH 6.0 (apical) or 7.4 (basolateral) with HEPES or MES accordingly. Monolayers were
incubated with “drug-free” transport medium for 20 minutes, after which the medium with the
diluted anthocyanins was introduced to the apical side. Aliquots were obtained from the
basolateral side every 15-30 minutes for 2 h and the basolateral volume was replaced with
fresh medium. The experiment was carried out at 37 °C with 5% CO2 in a humidified incubator.
Basolateral anthocyanin/phenolic concentrations were determined by HPLC as before to
calculate the apical to basolateral permeability. The apparent permeability coefficient (Papp), in
cm/s, was determined based on HPLC data for the amount of compound of interest transported
per time according to the formula Papp= (dQ/dt)(1/(AC0)) where dQ/dt is the steady-state flux
(mmol/s) based on the slope of the linear area of the absorption curve, A is the surface area of
the filter (cm2) and C0 is the initial concentration in the donor chamber (mM).32
After the completion of the transport experiment, phenolics from the cell layers were
extracted based on the method reported by Yi et al.33 Briefly, the cell layers were rinsed with
HBSS 3 times and scraped off the membrane using 0.5 ml of acidified methanol (0.01% v/v HCl).
The cells and methanol were collected and sonicated 15 min followed by centrifugation at 2000
xg for 5 minutes. The supernatant was collected and the cells were mixed with 0.5 ml of
acidified methanol, sonicated, and centrifuged 2 more times as before. The combined
supernatants were evaporated under N2 and then reconstituted in 0.6 ml of acidified methanol
for HPLC analysis.
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2.2.6 Statistical Analysis
Results are presented as mean ± SD. Values obtained by HPLC for non-fermented extract
characterization are presented as the mean of three repetitions, and had SE ≤ 1% (not shown).
Statistical analysis was performed using one-way analysis of variance (ANOVA). Separation of
means was performed by the Tukey’s Studentized Test (SAS®, version 9.2). Significant
differences were considered at an alpha level of 0.5.

2.3 RESULTS AND DISCUSSION
Characterization of phenolics in non-fermented anthocyanin-rich extracts deriving from
blueberry and black raspberry pomaces (Figure 2.1) revealed three major phenolics, namely
anthocyanins, gallic acid, and anthocyanidins (only found in black raspberry pomace extract),
and two minor phenolics, protocatechuic acid and p-coumaric acid. Further characterization of
anthocyanins (Table 2.1) revealed that blueberry anthocyanins were 57.6% malvidins and 21.5%
cyanidins, while close to 95% of black raspberry anthocyanins were cyanidins. The major
anthocyanins found were malvidin-3-galactoside and cyanidin-3-rutinoside in the blueberry and
black raspberry extract, respectively. These results are consistent with previous studies
evaluating the anthocyanin profile of whole berries.34-36 Additionally, black raspberry pomace
contained significantly more anthocyanin than blueberry pomace, which is consistent with a
previous study comparing blueberries (230 mg anthocyanin/100 g fruit) to black raspberries
(566 mg anthocyanin/100 g fruit).37 Previous studies evaluating fruit pomaces have focused on
grapes given its wide availability deriving from juice and wine processing. Authors have
reported blueberry pomace anthocyanins at levels of 1757 to 11900 mg/kg, however a
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breakdown of other phenolics or studies on anthocyanin profile of black raspberry pomace
were not found in the literature.38-40 Our results show anthocyanin contents of 1200 and 3800
mg/kg blueberry and black raspberry pomace, respectively. Differences with previous studies
may be due to the anthocyanin quantification method employed.

Figure 2.1. Effect of fermentation time on major (A) and minor (B) polyphenols in black
raspberry and blueberry pomaces. NF – Non fermented. Different superscripts in the same row
indicate significant differences between treatments.

Table 2.1. Anthocyanin characterization of berry pomace extracts.

% Total Anthocyanins

Compound
cyanidin-3-arabinoside
cyanidin-3-galactoside
cyanidin-3-glucoside
cyanidin-3-rutinoside
cyanidin-3-sambubioside-5-rhamnoside
delphinidin-3-galactoside
malvidin-3-arabinopyranoside
malvidin-3-galactoside
malvidin-3-glucoside
pelargonidin-3-glucoside
peonidin-3-galactoside
petunidin-3-glucoside
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Blueberry
7.1%
5.5%
8.9%

Black Raspberry

7.1%
68.8%
18.2%

5.4%
19.3%
23.8%
14.5%
6.0%
4.9%
10.7%

Fermentation of berry pomaces resulted in significant changes in phenolic profiles
(Figure 2.1). For both berries, anthocyanins, which were the major phenolic identified, were
completely degraded after 12 h of fermentation. Anthocyanidins, initially only found in nonfermented black raspberry significantly decreased after 12 h of fermentation. In contrast, gallic
acid from both berries significantly increased with fermentation. Minor phenolics
protocatechuic and p-coumaric acid significantly decreased with fermentation in black
raspberry, however no significant changes were observed for the same compounds in
blueberry. Caffeic acid was only identified in the fermented blueberry samples. For all identified
phenolics, no significant differences were observed between the 12 and 24 h fermentation
samples, thus 12 h fermentation samples were used for the transport experiment. Complete
degradation of anthocyanins after fecal inoculum incubation has previously been observed by
Fleschhut et al. and Keppler et al.41,42 For black raspberry, we hypothesize that bacterial
fermentation by the fecal microflora initially resulted in production of protocatechuic acid from
cyanidin as previously reported,41-43 however protocatechuic acid was further converted by the
microflora to gallic acid by hydroxylation as proposed by Kambourakis et al. 44 For blueberry, a
clear deglycosylation of anthocyanins into anthocyanidins was observed, however this was also
accompanied by an increase in gallic acid which may have derived from the O-demethylation of
syringic acid, the main microbial metabolite of malvidins.41,42
In the transport experiment, further transformation of major and minor phenolics from
both non-fermented and fermented berry pomaces was observed. Apparent permeability
(Papp) could only be calculated for protocatechuic acid in blueberry (BB), black raspberry (BRB),
and fermented black raspberry (FBRB), p-coumaric acid in BB and BRB, and anthocyanin in BRB
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(Table 2.2). Papp could not be calculated for any phenolics in fermented blueberry (FBB) due to
the apical to basolateral transport of compounds that were not initially in the apical side, but
derived from the degradation of anthocyanidins and gallic acid. Calculated Papp for
anthocyanin, protocatechuic and p-coumaric acid had values of 0.5x10-9 to 1.1x10-7 cm/s, which
according to previous authors correlates to a poor in vivo absorption of less than 1%.45,46 A
previous study reported anthocyanin transport efficiency in Caco-2 monolayers of 0.9-4.7%,
however a main difference with our study is that we did not utilize purified anthocyanins but
rather an anthocyanin rich extract.33 In comparison, a study evaluating a black currant extract,
resulted in no anthocyanins being detected in the basolateral side after 80 minutes, similar to
our results.47 A study evaluating the permeability of p-coumaric acid through Caco-2 cell
monolayers48 reported a basolateral recovery of 11%, however our recovery was more than
35%; this may be due to a synergistic effect of other phenolics in the matrix evidenced by
significant differences in the Papp of the same compound in different matrixes. Effect of
phenolic acids and polyphenols on the Caco-2 transport efficiency of various compounds has
previously been reported.49-51 Gallic acid (GA) transport through Caco-2 monolayers has
previously been reported at less than 1%,48 however our higher values in selected treatments
further confirm the synergistic/antagonistic effect of phenolics in the matrix.
Table 2.2. Apparent permeability coefficient (Papp) of phenolics in different berry matrixes.

Phenolic
Protocatechuic Acid
p -Coumaric Acid
Anthocyanin

Papp (10-9 cm/s)
Black Raspberry
Fermented

Blueberry
6.3 ± 2.28

a

27.1 ± 7.31

b

15.0 ± 6.79
-

a

86.6 ± 21.82
0.5 ± 0.12

b
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110.8 ± 52.25
-

c

A detail of the changes and absorption of phenolic compounds deriving from nonfermented and fermented berries can be observed in Figure 2.2. For blueberry, the phenolics
initially present were anthocyanin (ACY), p-coumaric acid (pCA), gallic acid (GA), and
protocatechuic acid (PCA). After the 2 h transport experiment period, all of the initial phenolics
were found on the apical side, in addition to anthocyanidin (ACD), caffeic acid (CA),
phologlucinol aldehyde (PG), syringic acid (SA), chlorogenic acid (CGA), ferulic acid (FA), phydroxybenzoic acid (HBA) and traces of ellagic acid (EA), while ACY greatly decreased to 3% of
the initial amount. Phenolics transported into the basolateral side were CA, SA, PG, GA, PCA,
pCA, and FA. Traces of vanillic acid (VA) were also found exclusively in the basolateral side.
Similar results were observed for black raspberry, where the initial phenolics ACY, ACD, GA,
PCA, and pCA were also found in the apical side after 2 h with increases in PCA but significant
decreases in ACY and ACD, however the ACY was better preserved, as 62% of the initial ACY but
only 10% of the initial ACD were recovered. In the apical side after 2 h SA, VA, CGA, HBA, pCA,
EA, CA, and traces of cinnamic acid (CNA) were also identified. The major phenolic transported
into the basolateral side, although not found in the apical side or the cell monolayer, was PG;
other phenolics transported into the basolateral side were PCA, VA, pCA, and CNA.
Results of the transport experiment of the fermented berry pomaces also displayed
changes in phenolic profiles (Figure 2.2). Although the initial profiles were very similar,
consisting in GA, ACD, pCA and PCA, the differences in individual anthocyanidins may have
contributed to the difference in final profiles. For fermented blueberry, all the initial
compounds except ACD were found in the apical side after 2 h in addition to PG, HBA, SA, VA,
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Figure 2.2. A Phenolic profiles of recovered Caco-2 permeability experiment fractions: apical
initial (AI), apical final (AF), basolateral (B), and cell monolayer (M). B Breakdown of minor
compounds. *Molar amounts have been normalized to the major phenolic identified,
anthocyanin for non-fermented extracts or gallic acid for fermented extracts, where the major
phenolic =1.
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FA, and traces of CNA. Transport to the basolateral side only occurred for HBA, SA, PCA,
VA,pCA, and FA. Similarly, for fermented black raspberry all the initial compounds except ACD
were found in the apical side after 2 h, but the additional compounds found were HBA, EA, and
VA. Phenolics transported to the basolateral side for fermented black raspberry were HBA, PG,
PCA and VA. For all the treatments, phenolics found in the cell monolayers generally
corresponded to those transported to the basolateral side, however the recovered amounts
generally represented less than 10% of the transported fraction.
Major reductions in anthocyanins after exposure to Caco-2 cells in culture media or
HBSS have been previously reported to levels up to less than 10% and 20%, respectively,
depending on the individual anthocyanin due to oxidation and physiological actions of the
cells.33,47,52 In the study by Yi et al.33 individual anthocyanins were recovered in the basolateral
side up to 6%, however this study also demonstrated that the transport efficiency of total
anthocyanins was affected by the individual anthocyanins present in the matrix, sugar moieties,
and anthocyanidin base, which may explain why anthocyanins were identified in the basolateral
side only for BRB. Although no anthocyanidins were identified in the basolateral side for any of
the treatments, deglycosilation of anthocyanins from BB and BRB on the apical side after 2 h
was evident. Several authors have observed deglycosilation of polyphenols by intestinal
cells.42,53-55 Enzymes involved in deglycosilation of anthocyanins may include lactase-phlorizin
hydrolase and β-glucosidase from the intestinal mucosa.53,55
After deglycosylation, further degradation of anthocyanidins typically occurs with the
fission of the C-ring of the anthocyanin resulting in phloroglucinol aldehyde and phenolic
acids.42,43 Theoretically, the main phenolic acids deriving from BB would be SA (from malvidins),
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PCA (from cyanidins), 3-O-methylgallic acid (from petunidin) GA (from delphinidin), and VA
(from peonidin); while from BRB we would expect to find PCA and HBA (from pelargonidin).41,52
The aforementioned compounds corresponded to those found in our experiment both in the
apical and basolateral sides; however other phenolics were identified such as EA, CNA, CGA, CA,
and FA. Structures of anthocyanidins and the phenolic acids identified in this study are shown in
Figure 2.3. EA may have derived from metabolism of ellagitannins,56 which were not a target for
quantification in the initial extracts given our interest in the anthocyanins and phenolic acids.
EA absorption into the basolateral layer was extremely low or non-detectable, perhaps due to
its large molecule size as compared to other phenolic acids. CNA, CGA, CA, and FA, all
hydroxycinnamic acid derivatives may have resulted from anthocyanin/anthocyanidin
degradation by the cells in a manner different from the classical aldehyde-phenolic acid C-ring
fission or from EA degradation. CGA, the largest molecule of these four, was not detected in the
basolateral side for any treatments, probably due to its size in a similar manner to EA. Previous
studies have reported basolateral transport of pure CGA at less than 0.1% and CA at 1.5%,49
however for BB the basolateral transport of CA in the matrix represented 25% of that recovered
in the apical layer after 2 h.
Previous studies have reported unchanged anthocyanin absorption into the
bloodstream by humans and other species, however while these studies typically involve the
consumption of highly concentrated extracts and not the berries themselves, recoveries are
quite low (less than 0.5%) and do not represent a normal berry consumption setting. 57-60
Authors have even named anthocyanins and anthocyanidins as the “least well-absorbed
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Figure 2.3. Structures of anthocyanidins and their corresponding breakdown products, ellagic
acid, and hydroxycinnamic acid derivatives relevant to this study.
polyphenols”.61 Studies also show that the site for intact anthocyanin absorption may be the
stomach, a mechanism which we did not simulate in our model.62 In addition, authors have
noted that anthocyanin metabolites may have undergone further transformation when
excreted in the urine, a common method to quantify absorption, and thus may impede
individual phenolic quantification.63
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In this study, we have demonstrated major changes in phenolic profiles of BB and BRB
pomaces due to colonic fermentation by human fecal microflora and further absorption by
intestinal cells. Our results suggest that BB and BRB pomaces represent a source of bioavailable
polyphenols and could be utilized in food formulations as a functional ingredient due to their
inherent fiber content and phenolic availability after fermentation. In addition, we have
proposed a model to screen bioavailability of food polyphenols in vitro, allowing for a detailed
study of metabolites in a cost and time efficient manner as compared to in vivo studies.
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CHAPTER 3
IN VITRO SCREENING OF BLUEBERRY AND BLACK RASPBERRY POMACE PHENOLICS AND THEIR
ANTI-INFLAMMATORY POTENTIAL IN CORONARY CELLS

3.1 INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death in the United States
accounting for 33.6% of the deaths in the country. More than 1 out of 3 American adults have
at least one type of CVD.1 Low grade chronic inflammation, a major consequence of obesity, is a
widely recognized risk factor for CVD and other diseases such as diabetes and some cancers.2-8
Previous studies, as well as research carried out in our laboratory, have shown a positive
correlation between free fatty acids (FFA) in plasma and inflammation scores.9-12 It is now
widely accepted that atherosclerosis, a form of CVD, is the result of a chronic inflammatory
process, leading to atherosclerotic plaque rupture and formation of thrombus which results in
events such as heart attack and stroke. The increased understanding of this type of chronic
diseases has created interest in new opportunities for health promotion. Foods and some food
production byproducts, such as berry fruits and pomace offer an attractive means to deliver
anti-inflammatory compounds in a convenient and well established form.
Anthocyanins are a group of flavonoids commonly found in many fruits and
vegetables.13,14 Anthocyanins exhibit characteristic red, blue, or purple colors in fruits such as
blueberries (Vaccinium spp.) and black raspberries (Rubus occidentalis). In addition to color
anthocyanins have been shown to exhibit antioxidant capacity.15 Intakes in the United States
have been estimated at 12.5 mg/day/person.13 In recent studies it has been shown that
anthocyanins exhibit a range of biological activities, including vascular anti-inflammatory effects
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and influence in blood vessels and platelets, leading to the suggestion that they reduce the risk
of cardiovascular disease (CVD).16-18 It has been shown that in vivo absorption of anthocyanins
is very low, raising blood plasma levels to levels of the ng/ml order.19-21 Anthocyanins undergo
major changes during fermentation by the microbiome in the colon. Fermentation in the
microbiome results in the production of phenolic acids that exhibit excellent absorption into
the bloodstream and as a result may be responsible for some of the beneficial health effects
attributed to anthocyanins.22-25 It is postulated that the smaller size of the phenolic acids from
fermentation accounts for the enhanced absorption.26,27 We have also demonstrated these
effects by utilizing an in vitro model for digestion, colonic fermentation and transport through
Caco-2 cell monolayers (see Chapter 2). We have further been able to propose a profile of the
intestinal transport products of the colonic fermentation of berry pomace.
Several biomarkers of inflammation have been associated with CVD, including
interleukin-6 (IL-6), interleukin-8 (IL-8), monocyte chemoattractant protein 1 (MCP-1), Creactive protein (CRP), and others.28-33 Additionally, other circulating biomarkers have been
proposed as anti-inflammatory such as interleukin-10 (IL-10) and interleukin-1 receptor
antagonist (IL-1ra).34-36 It has been proposed that berry anthocyanins are cardioprotective;
however, the mechanism by which CVD risk is reduced is not well understood. Furthermore, the
potential anti-inflammatory effects of a combination of phenolic acids resulting from the
fermentation and absorption of said berries has not been explored.
The approach of this research was to test the impact of blueberry and black raspberry
anthocyanin-rich extracts and phenolic acid mixtures representative of berry pomace colonic
fermentation and absorption on the expression of various inflammation markers in human
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coronary arterial smooth muscle (HCASM) and endothelial (HCAE) cells in response to
stimulation with palmitic acid (PA). In this study, a model for screening food bioactives and
induction of inflammation with free fatty acids in human coronary cells has been proposed as a
time saving and cost efficient alternative to in vivo studies.

3.2 MATERIALS AND METHODS
3.2.1 Materials
Blueberry (Vaccinium spp.) and black raspberry (Rubus occidentalis ‘Munger’) pomaces
were provided by Milne Fruit Products (Prosser, WA) and freeze dried in a VirTis Genesis pilot
lyophylizer (Warminster, PA). Palmitic acid (PA), p-hydroxybenzoic acid (HBA), protocatechuic
acid (PCA), vanillic acid (VA), syringic acid (SA), ellagic acid (EA), p-coumaric acid (pCA), ferulic
acid (FA), and fatty acid free bovine serum albumin (BSA) were purchased from Sigma Aldrich
(St. Louis, MO). Human Primary Coronary Artery Endothelial (HCAE) and Smooth Muscle
(HCASM) Cell lines were purchased from ATCC (Manassas, VA) and proceeded from healthy
adult volunteers. All other reagents were of analytical or cell culture grade and obtained from
Sigma Aldrich (St. Louis, MO). Water was Milli Q (Millipore Corporation, MA) and autoclaved as
required for all the studies.
3.2.2 Anthocyanin Extraction and Characterization
Anthocyanin rich extracts were obtained from blueberry (BB) or black raspberry (BRB)
pomace using the acidified-methanol method.37 Briefly, pomace was homogenized with 2
volumes of acidified methanol (0.01% v/v HCl) and macerated for 1 h, filtered through
Whatman 1 filter paper and re-extracted twice until a faint-colored extract was obtained. The
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extract concentrated in a rotary evaporator to remove the methanol, freeze-dried, re-dissolved
with sterile water, and sterile filtered. Anthocyanins and phenolics were quantified by HPLC
using the method developed in our laboratory by Jang and Xu that has been previously
described.38,39
3.2.3 Preparation of Palmitic Acid and Phenolic Solutions
PA was conjugated to BSA in a 12.5 mM solution based on the methods
developed by McIntosh, Toborek and Henning, and van Greevenbroek el al. 40-43 Briefly, cell
culture grade PA was aseptically weighed and dissolved in hexane and mixed with an equimolar
amount of KOH, dried under nitrogen and immediately diluted in warm sterile water. The
solution was then combined with a 30% BSA solution (30% BSA in DPBS+HEPES, pH 7.2, sterile
filtered) and the pH was readjusted to 7.2. The solution was aliquoted into sterile vials, flushed
with argon, and frozen at -80 °C. Aliquots of the BSA solution were used as control. Volumes of
these solutions did not exceed 2% in the media.
Dilutions of berry extracts and phenolic acids were prepared immediately before the cell
culture experiments. Berry extract stocks were prepared to achieve a 1 mM concentration,
based on initial anthocyanin (ACY) + anthocyanidin (ACD) concentrations (BB=3.79 mM ACY;
BRB=7.92 ACY + 2.98 ACD=10.9 mM) by diluting the extract with DPBS+HEPES at pH 7.4.
Subsequent dilutions were prepared to achieve concentrations of 20, 10, and 5 μM to be added
directly to the cell culture media at volumes not exceeding 0.5%. Phenolic solutions were
prepared based on previous experiments dealing with the absorption of phenolics from
fermented berry pomaces through Caco-2 monolayers. Table 3.1 illustrates the average
composition of fermented BB and BRB permeates. Phenolic stocks were prepared to a
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concentration of 10 mM with sterile water, based only on the phenolic acids deriving from the
direct degradation of ACYs, namely HBA, PCA, VA, and SA (FBB=3.58mM HBA + 1.45mM PCA +
1.28mM VA + 3.69mM SA = 10mM; FBRB=6.43mM HBA + 2.31 mM PCA + 1.26 VA = 10mM);
however other phenolic acids found in the permeate (EA in FBRB, pCA and FA in FBB) were also
included in the stocks at the appropriate concentrations as shown in Table 3.1. Subsequent
dilutions were prepared at concentrations of 20, 10, and 5 μM with DPBS+HEPES at pH 7.4 for
direct addition to the media at volumes not exceeding 0.5%.
Table 3.1. Average molar phenolic acid profile of fermented blueberry and black raspberry
pomace Caco-2 permeates. Values have been normalized for the concentrations of HBA, PCA,
VA, and SA to add to 10.
Fermented
Fermented
Phenolic Acid
Blueberry
Black Raspberry
p-hydroxybenzoic acid
3.58
6.43
Protocatechuic acid
1.45
2.31
Vanillic acid
1.28
1.26
Syringic acid
3.69
Ellagic Acid
0.34
p-coumaric acid
0.94
Ferulic Acid
1.18

3.2.4 Cell Culture and Inflammation Model
Cell lines of HCAE and HCASM cells were grown using Cascade Medium 200 or 231
(Gibco, Portland, OR), respectively. Cells were fed every other day until 80% confluence and the
contents of each flask split into 2 or 3 subsequent flasks. The cells were lifted with Cascade
Trypsin solution which was then neutralized with CMF-PBS, followed by centrifugation at 180 xg
for 3 minutes and suspension at a density of 10,500 cells/cm2 in their corresponding media (see
above) using T-25 flasks, 24-well plates or 96-well plates as appropriate. Cells were incubated at
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37 °C and 5% CO2 in a humidified incubator (Sanyo Biomedical, Wood Dale, IL) for all
treatments.
Anti-inflammatory assessments were performed using two approaches: prevention and
intervention. For the prevention approach, cells were treated with anthocyanins or phenolics
at 100, 50 or 25 nM in the media (based on human plasma anthocyanin levels in the literature
ranging 26-103 nM19-21,44) followed by 2.5 (HCAEC) or 8 h (HCASM) of incubation; PA was then
added for a final concentration of 250 μM, and the cells were incubated for a total of 8 or 24 h.
For the intervention approach the same PA and phenolic doses were used, except cells were
first incubated with PA followed by treatment with phenolics. A control to which neither
extracts nor PA was added was included in each group.
After incubation at specified times (HCAEC 8 h, HCASM 24 h) were completed, cell
culture supernatants were harvested and levels of inflammation biomarkers IL-6, IL-8, MCP-1,
TNFα, IL-1β, IL-10, and IL-1ra were measured by ELISA kits from PeproTech (Rocky Hill, NJ) or
R&D Systems (Minneapolis, MN). Cells were washed twice with DPBS and removed from the
culture flasks or plates using Cascade trypsin solution that was then neutralized with 5% FBS in
DPBS; the trypsinized cells were centrifuged at 180 xg for 7 minutes, the supernatant removed,
and the pellet frozen at -80 °C for further analysis. Cell viability was assessed using the
Promega CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (MTS) (Madison, WI).
Biomarker levels were calculated and adjusted to be expressed as a percentage of inflammation
based on the PA control (100% stimulation) and corrected for cell viability.
RNA was extracted from cell pellets using the RNeasy® Mini kit from Qiagen (Valencia,
CA). Following the manufacturer’s protocol, 1 x 106 cells were disrupted and homogenized
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using the QIAshredder homogenizer. Ethanol was added to the lysate to bind the RNA to the
membrane in the spin column, residual DNA was digested on the column using the RNase-Free
DNase Set, and the RNA was eluted with RNase-free water. RNA in the elute was measured by
UV spectrophotometry using the NanoDrop 2000 from Thermo Scientific (Wilmington, DE)
blanked with RNAse-free water. Before PCR analysis, cDNA was synthesized from 500 ng of RNA
from each sample using the RT2 First Stand Kit from Qiagen which consists in the elimination of
genomic DNA followed by reverse transcription. Real time PCR was performed on selected
samples using the custom RT2 Profiler PCR array CAPH10908 with HotStart DNA Taq Polymerase
and SYBR Green fluorophore from Qiagen that included 16 target genes in a 96-well plate
format (16x6), namely: IL6, IL8, IL10, IL18, CCL2, IL1B, PTGS2, NFKB1, NFKB2, TLR2, TLR4, TNF,
ICAM1, VCAM1, MAPK14, and GAPDH (housekeeping gene). The array was processed in the
CFX96 Touch™ Real-Time PCR cycler equipped with CFX Manager™ Software and automatic
threshold cycle (CT) calculation (Bio-Rad Laboratories, Hercules, CA). The cycling conditions used
were 10 minutes at 95 °C for polymerase activation, followed by 40 cycles of annealing for 15 s
at 95 °C and elongation for 1 min at 60°C with fluorescence data collection. A melting curve (65
to 95 °C at a rate of 0.5 °C per 5 s) was also performed at the end of the cycling program to
verify PCR specificity, evident by a single peak appearing in each reaction at temperatures
greater than 80°C. CT values were processed with the SABiosciences PCR Array Data Analysis
Web-based software. The software calculates ΔCT based on the housekeeping gene (GAPDH),
then calculates the normalized gene expression in the samples using the formula

. The

normalized gene expression of the sample is divided by the control (PA) to obtain the fold
change, which is then converted to fold regulation.45 Fold regulation equals fold change for
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values greater than 1, fold regulation is the negative inverse of fold change for values less than
1. The software also performs a cluster analysis of the dataset to generate a heat map with
dendograms to indicate co-regulated genes across samples.
3.2.5 Statistical Analysis
Results are presented as mean ± SE. All tests were carried out in triplicate. Statistical
analysis was performed using one-way analysis of variance (ANOVA). Separation of means was
performed by the Tukey’s Studentized Test (SAS®, version 9.2). Differences were considered
significant at p≤0.05.

3.3 RESULTS AND DISCUSSION
Berry anthocyanins are widely recognized for their antioxidant properties; however
their effect on the inflammatory pathway has not been explored in detail. In this study we
evaluated how blueberry and black raspberry anthocyanin-rich pomace extracts and their
phenolic acid products derived from colonic fermentation of pomaces affect the expression of
various inflammatory biomarkers.
IL-6 levels in HCASM cells (Figure 3.1, see A) were unchanged in all the treatments
except for BRB in the intervention approach, where IL-6 dose-dependently increased to levels
significantly higher than control (p<0.05). IL-8 in HCASM cells (Figure 3.1, see A) also showed
dose-dependent increases for BRB in the intervention approach and FBRB in the prevention
approach; however overall IL-8 levels were higher for all treatments in the prevention approach
as compared to intervention. In contrast, IL-8 levels in HCAE cells (Fig 4.1B) were overall lower
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Figure 3.1. Changes in levels of IL-6, IL-8, and MCP-1 in human coronary arterial smooth muscle
HCASM (A) and endothelial HCAE (B) cell supernatants as influenced by berry anthocyanin-rich
extracts or phenolic acid mix (fermented) in the intervention and prevention approaches. *
Treatment is significantly different (P<0.05) from BSA control. ^ Treatment is significantly
different (P<0.05) from PA control. Bars that are not displayed correspond to levels too low to
be detected in the supernatant.
in the prevention approach as compared to intervention, and no clear dose-dependent
responses were observed for any of the treatments. MCP-1 behaved similarly to IL-8 in HCASM
cells (Figure 3.1, see A), with overall higher levels for all treatments in the prevention approach
and increasing dose-dependent response for BRB in the intervention approach, but also
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decreasing dose-dependent responses for FBB in both approaches. MCP-1 in HCAE cells (Figure
3.1, see B) was reduced to levels similar to the BSA control only by FBRB at 25nM in both
approaches, and BB and FBB at 50nM in the prevention approach.
Supernatant levels of TNFα in HCASM cells (Figure 3.2) showed dose-dependent
decreases for BB in both approaches and FBRB in the prevention approach, however the
greatest reductions in TNFα (to levels similar to the BSA control) were observed for all levels of
FBRB in the intervention approach and for FBB and BRB in the prevention approach,
independent of dose. Overall, the prevention approach resulted in lower levels of TNFα in
HCASM cell supernatants. In contrast, IL-1β levels were overall higher for all treatments in the
prevention approach. IL-1β also displayed dose-dependent decreases in BB and FBB in both
approaches, and FBRB in the prevention approach. A slight dose-dependent increase in IL-1β

Figure 3.2. Changes in levels of IL-1β and TNFα in human coronary arterial smooth muscle cell
supernatants as influenced by berry anthocyanin-rich extracts or phenolic acid mix (fermented)
in the intervention and prevention approaches. * Treatment is significantly different (P<0.05)
from BSA control. ^ Treatment is significantly different (P<0.05) from PA control.
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was observed for BRB in the intervention approach.
Supernatant levels of proposed anti-inflammatory cytokines IL-1ra and IL-10 were also
evaluated in the cell culture supernatants (Figure 3.3). Dose-dependent decreases of IL-1ra
were observed only in HCASM cells for BB in both approaches, and FBB and FBRB in the
prevention approach; however both cell lines displayed overall lower IL-1ra levels comparable
to the BSA control in treatments performed in the prevention approach. IL-10 dose-dependent
reductions to levels similar to the controls were only observed for BB in the intervention
approach, and FBB and FBRB in the prevention approach. In contrast, FBRB in the intervention
approach resulted in a dose-dependent increase; however a difference between overall
approaches for IL-10 was not clearly evident. IL-10 was not detected in the supernatants of
HCAE cells in this study.
Gene expression of inflammation related genes in HCASM cells is shown in Figure 3.4.
Only those genes that resulted in fold regulation values higher than 2 or lower than -2 are
depicted. Fold regulation of IL6, IL8, IL1B, NFKB1, NFKB2, TLR4, and MAPK1 remained between
2 and -2 for all treatments, while significantly being down-regulated for BSA, BB, and BRB
controls at values between -2 and -12 (not shown). TLR2 was down regulated by all treatments
except FBRB 25nM in the intervention approach, and this down regulation was overall more
effective in the prevention approach. TNF significantly differed from both controls only with
BRB 100nM and FBRB 25nM in the prevention approach, where it was up-regulated. CCL2 was
more effectively down-regulated by all treatments in the prevention approach, however no
treatment achieved down regulation similar to the control. ICAM1 was up regulated exclusively
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Figure 3.3. Changes in levels of IL-1ra and IL-10 in human coronary arterial smooth muscle (A)
and endothelial (B) cell supernatants as influenced by berry anthocyanin-rich extracts or
phenolic acid mix (fermented) in the intervention and prevention approaches. * Treatment is
significantly different (P<0.05) from BSA control. ^ Treatment is significantly different (P<0.05)
from PA control.
by FBB 25nM in the prevention approach, while VCAM1 was up regulated exclusively by BB
25nM in the prevention approach. PTGS2 was best down regulated by BRB 25nM in the
intervention approach. Noticeably, none of the tested treatments achieved a down regulation
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of the ICAM1, VCAM1 or PTGS2 genes to levels comparable to the BSA control; however, the
entire observed gene up regulations in SMC were less than 3-fold.

Figure 3.4. Changes in fold regulation in human coronary arterial smooth muscle cell gene
expression as influenced by berry anthocyanin-rich extracts or phenolic acid mix (fermented) in
the intervention and prevention approaches.
Gene regulation in HCAE cells is shown in Figure 3.5. For IL6 and PTGS2 (Figure 3.5, see
A), none of the individual treatments was able to down regulate the genes to the BSA control
levels except PTGS2 with BRB 50 nM in the prevention approach, in fact most treatments up
regulated the genes up to 12-fold, with apparent dose-dependent up regulation for both FBRB
treatments and down regulation for BB in the prevention approach. CCL2 (Figure 3.5, see A)
was down regulated by most treatments, although values similar to control were only achieved
by FBB 100nM in both approaches. Dose-dependent up regulation was also observed for both
FBRB treatments. NFKB1 (Figure 3.5, see A) was up regulated to levels similar or higher than the
BSA control, except for FBB and BRB in the prevention approach, both of which slightly down
regulated the NFKB1 expression. NFKB2 (Figure 3.5, see B) was down regulated by all the tested
54

Figure 3.5. Changes in fold regulation in human coronary arterial endothelial cell gene
expression as influenced by berry anthocyanin-rich extracts or phenolic acid mix (fermented) in
the intervention and prevention approaches.
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treatments; however levels similar to the BSA control were achieved by FBB and BRB in the
prevention approach. Similarly, the gene expression of IL18, TNF and IL1B was down regulated
by all the treatments evaluated, however the down regulation was not as low as the BSA
control except IL1B for BB 25nM in the prevention approach. TLR4 and MAPK1 (Fig 4.5B)
remained up regulated both in the BSA controls and the treatments at similar levels, thus all
treatments were effective in overcoming the effects of PA on the expression of these two
genes. Gene expression of IL8 and ICAM1 (Figure 3.5, see C) was up regulated both in the BSA
control and the treatments, however all treatments showed an up regulation at a much higher
fold than the BSA control (up to 16-fold as compared to BSA). Additionally, this up regulation
appeared to be dose-dependent for FBRB in both approaches. Interestingly, the lower up
regulations observed for ICAM1 were for treatments in the prevention approach. Finally, the
gene expression of IL10 (Figure 3.5, see C) was down regulated in a similar magnitude by all
treatments (28- to 318-fold), however these down regulations were not comparable to that
observed in the BSA control (2029-fold), thus the treatments had limited effect over this gene.
The cluster analysis of the gene expression in HCASM cells (Figure 3.6, see A) displays
co-regulation of genes NFKB1 and NFKB2, IL8 and PTGS2, ICAM1 and IL1B, TNF and CCL2, TLR4
and MAPK1. Additionally, the heat map allows us to graphically identify the most effective
treatments in regulating the gene expression similar to BSA control. Overall, black raspberry
treatments were the most effective in HCASM cells, resulting in gene expression similar to BSA
control when the prevention approach was used with either original extract or after
fermentation. In the tests with blueberry extracts and fermentation products it is difficult to
differentiate which of the two approaches was the most effective, however it was observed
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Figure 3.6. Gene expression clustergram displaying heat map indicating co-regulated genes
across individual samples of human coronary arterial smooth muscle (A) and endothelial (B)
cells.
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that in the prevention approach the fermented blueberry pomace resuted in overall lower gene
expression, while in the intervention approach the non-fermented extract was more effective.
Gene co-regulation in HCAE cells (Figure 3.6, see B) displayed more distinct clustering than in
HCASM cells. Strong co-regulation was observed for TNF, NFKB2, IL10, IL18 and IL1B, while coregulation of TLR4-MAPK1 and IL8-PTGS2 occured in the same way as the corresponding genes
in HCASM cells. Co-regulation of IL6 and ICAM1 was also observed in EC. Overall, treatments in
the prevention approach were the most effective in modulating gene expression similarly to
BSA control in HCAE cells. Within the evaluated treatments in HCAE cells, BRB at 50nM in the
prevention approach was the dose that modulated all the genes closer to the BSA control than
any other dose. Interestingly, though, BB at 25 nm and FBRB at 100 nM in the prevention
approach resulted in high overall gene expression, suggesting a hormetic effect in the
prevention approach for HCAE cells.
We hypothesize that the reduction of inflammatory biomarkers was mainly due to an
effect of the berry anthocyanins or phenolic acids on the free fatty acid-induced
proinflammatory transcription of NF-κB. In chronic heart failure NF-κB is activated by increased
circulating TNF-α and other pro-inflammatory stimuli which in our study were substituted by
PA. Activation of NF-κB promotes gene transcription of proinflammatory cytokines (IL-6, TNF-α),
chemokines (IL-8, MCP-1) and adhesion molecules (ICAM-1).28 Circulating cytokines IL-6 and
TNF-α have shown significant increases in patients with heart failure. 46 Chemokines such as IL-8
in turn promote the generation of free radicals which can lead to cell oxidative stress.47 This
hypothesis is supported by our results on the protein levels and gene expression of IL-8, IL-6
and MCP-1 (CCL2); these three biomarkers were reduced in similar ratios, especially as
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observed on the response of smooth muscle cells. Similar results have been observed in studies
using endothelioma and human gastric cancer cells.48 Inhibition of UV-induced NF-κB activation
by black raspberry methanol extracts has also been observed in mouse epithelial cells. 49
Additionally, in the current study up- or down-regulation changes in the gene expression of
NFKB1 and NFKB2, which correspond to the p-50 and p-52 subunits of NF-κB respectively, were
generally accompanied by corresponding changes in various biomarkers including IL-8, PTGS2
(COX-2), IL-6, and ICAM-1 in both cell lines (Figure 3.6). This may further confirm our hypothesis
that anthocyanin and their degradation products have an effect on NF-κB transcription.
Additionally, similar effects of both anthocyanin and their degradation products may suggest
anthocyanin degradation by the coronary cells.
Reduction in the expression of COX-2 in HCASM is in agreement with previous studies of
the anti-inflammatory properties of anthocyanins.50,51 Cyanidin from tart cherries at
concentrations of 60-90 µM have shown to inhibit COX-2 synthesis from arachidonic acid by
reducing the activity of prostaglandin endoperoxide H synthase-1 and -2 (PGHS-1, and -2) as
compared to aspirin, ibuprofen, and naproxen; however pure anthocyanins do not exhibit this
inhibitory effect and at high concentrations even increase the enzyme activity.50 This suggests
that free aglycons in our berry extracts were responsible COX-2 inhibition by this specific
mechanism. The greatest inhibition of COX-2 expression observed in cells treated with black
raspberry extract, which is richer in cyanidins, suggests that this was the mechanism of action.
Macrophage expression of PGE2 has also been shown to be inhibited by raspberry
anthocyanins; however, anthocyanin rich extracts, especially black raspberry, promoted greater
inhibition of COX-2 in the prevention approach of our study, also suggesting that the cyanidins
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in black raspberry exhibit stronger anti-inflammatory potential than the malvidins in
blueberry.51
Similar dose-dependent reductions of IL-1β and IL-1ra in most treatments, especially in
the prevention approach for both cell lines indicate an effect in the activation of the IL-1
system, since levels of IL-1ra have been shown to better correlate with the activation of
immune and inflamatory systems than IL-1 (α and β) which generally appears in very low
levels.52,53 High IL-1ra levels observed mostly in the intervention approach with both cell lines
may indicate that the cells had initiated a process to counteract the inflammation, since IL-1ra
has been proposed as an anti-inflammatory protein that is inducible by IL-6.54 Similar
supernatant protein levels of IL-6 and IL-1ra in HCASM support the previous author’s views.
Additionally, TNFα has been identified as the main activator of the IL-1 system, which in our
study was evidenced by similar trends in TNFα and IL-1β supernatant protein levels in HCASM
cells and gene expression in both cell lines.28
IL-18 has been proposed as an activator of interferon (IFN)-γ in atherogenesis, and has
been shown to be activated by stimuli including IL-1β, TNFα and LPS.55 In our study, IL-18 gene
expression was closely co-regulated with IL-1β, supporting the proposed activation mechanism;
however the gene expression of IFN-γ was not evaluated in our study.
MAPK (p38) has been shown to regulate the production of TNFα, IL-1β and COX-2 as
well as some of the effects of TNFα.56 However, gene expression of MAPK1 (p38) and its coregulated gene TLR4 in our study was not significantly affected by the evaluated treatments,
similarly to a previous study reporting no p38 changes in arteries displaying diabetes-induced
inflammation as evidenced by elevated levels of IL-6, TNFα and MCP-1.57 This further supports
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our hypothesis that the modulation of inflammation in this study was due to an effect in the
NF-κB cascade. In contrast, the down regulation of TLR2 in HCASM cells observed for all the
treatments in the prevention approach suggests that pre-treatment with berry extract or their
correspondent phenolic acids inhibited the pattern recognition of TLR2 towards cytokines or PA
as a pro-inflammatory stimuli. It has been shown that TLR2 expression in vascular cells
increases with inflammatory cytokines stimulation and in turn results in increased production of
cytokines and chemokines.58,59
A hormetic effect of berry anthocyanins and their fermentation products was observed
in the current study. For almost all biomarkers a clear preconditioning effect was observed in
the prevention approach, where the inflammatory response to PA was significantly lower to
that observed in the intervention approach. Additionally, high inflammatory responses at low
phenolic doses in some of the treatments are also indicative of a hormetic effect. Induction of
inflammation for the highest phenolic doses in some of the treatments may suggest low-grade
toxicity (pro-inflammatory effect) as observed before with black carrot and strawberry
extracts.45,46 These characteristics are typical of hormesis and have been observed in other
phytochemicals such as chalcone, ferulic acid, green tea polyphenols, and others.60
The results of this study suggest that a preventive approach is generally more effective
than intervention when using physiological levels of anthocyanin-rich berry extracts or their
fermentation products to reduce the free fatty acid-induced expression of proinflammatory
biomarkers in human arterial coronary cells. Additionally, we have shown that the phenolic
acids deriving from the fermentation of blueberry and black raspberry pomaces are equally or
more effective in modulating the inflammatory response in human coronary arterial cells, thus
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suggesting that these phenolic acids may be responsible for the beneficial effects commonly
attributed purely to anthocyanins deriving from the consumption of berries in vivo. Although
we recommend further studies be carried out to evaluate the correspondence of our model to
an in vivo setting, the results of our study suggest that blueberry and black raspberry pomaces
have the potential to be cardio protective by reducing low grade inflammation induced by
circulating palmitic acid, thus the supplementation of these byproducts in foods could
represent a cost-efficient approach to delivering phenolic compounds that may prevent or
delay the progression of inflammation to cardiovascular disease.
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CHAPTER 4
CONCLUSIONS AND FUTURE STUDIES

4.1 CONCLUSIONS
An in vitro model has been developed and utilized to characterize the products of
colonic fermentation and absorption of blueberry and black raspberry pomace phenolics, and
evaluate the potential efficacy of these products compared to anthocyanin-rich extracts as
potential anti-inflammatory compounds in fatty acid-induced inflammation. Careful review of
the literature provides a rational foundation justifying this work. Circulating free fatty acids
have been identified as a risk factor for inflammation and resulting cardiovascular disease. It
has been previously established that berry anthocyanins are very poorly absorbed, and undergo
transformation in the intestine. A model of colonic fermentation together with absorption
through Caco-2 cells allowed us to profile the phenolics deriving from the fermentation of berry
pomaces, as well as the absorption products. Finally, there is evidence that anthocyanins from
berries can be cardioprotective by reducing inflammation. The use of cardiovascular cells
allowed us to demonstrate that the phenolic acids deriving from the fermentation and
absorption of berry anthocyanins may be responsible for the inflammation-lowering properties
attributed to berries.
Chapter 2 explored the transformation of blueberry and black raspberry pomace
phenolics through an in vitro model of digestion and colonic fermentation using fecal inocula
accompanied by absorption through Caco-2 monolayers. HPLC characterization revealed that
antocyanins, the predominant phenolic in berry pomaces, are fully degraded into
anthocyanidins and phenolic acids after 12 h of colonic fermentation. Anthocyanin-rich extracts
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or the anthocyanidins and phenolic acids deriving from fermentation are further degraded and
transformed in the absorption process through Caco-2 cells. The study allowed us to profile the
phenolic acids that could potentially be present in the bloodstream after berry pomace
digestion and absorption.
Chapter 3 evaluated the potential anti-inflammatory effect of phenolic acids deriving
from the fermentation and absorption of blueberry and black raspberry pomaces as compared
to anthocyanin-rich extracts. Studies were carried out in two approaches, intervention and
prevention, in human coronary arterial endothelial and smooth muscle cells stimulated with
palmitic acid. Inflammation was assessed by the expression of supernatant proteins as well as
gene expression in the RNA. The prevention approach showed to be the most effective in
maintaining inflammation markers at levels close to baseline. Additionally, the fermentation
and absorption products of both blueberry and black raspberry pomaces were equally or more
effective than the anthocyanin-rich extracts. Gene expression analysis allowed us to propose
that the mechanism of action is through the effect on NF-κB transcription. This study showed
that berry pomaces, previously considered a waste product, can be used in foods to deliver
phenolic compounds that may prevent inflammation in cardiovascular cells.

4.2 FUTURE STUDIES
The food bioactive screening model than we have proposed in this dissertation could
represent a time and cost-efficient approach to in vivo studies to explore the anti-inflammatory
potential of foods in a small scale. The model of fermentation and absorption could be applied
to evaluate other fruit pomaces or food byproducts for the delivery of bioactive compounds
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and thus reduction of waste in the food industry. Additionally, further application studies
should be carried out to explore the use of blue and black raspberry pomaces in food products
such as breakfast cereals, nutritional bars, and drinks.
We also suggest the further development of a model where endothelial and smooth
muscle cells are co-cultured. This model would provide a more time-efficient approach at
screening food bioactives in cell culture. At the same time, the cell co-culture may represent a
more biologically relevant model.
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